Table 5.
Outcomes from control (SOC) treatment for moderate COVID-19 patients (N = 60)
| Variables | Days of admission (mean ± SD) | 7 days after admission (mean ± SD) | 14 days after admission (mean ± SD) | p-values (days: 1, 7) | p-values (days:7, 14) |
|---|---|---|---|---|---|
| RBS (mmol/L) | 14.817 ± 6.270 | 15.682 ± 5.024 | 15.781 ± 4.02 | 0.1098, 0.2197 |
0.2295, 0.4590 |
| WBC (K/µL) | 23.720 ± 29.96 | 28.600 ± 18.86 | 15.286 ± 3.19 | 0.0943, 0.1886 |
0.0055**, 0.0109** |
| Neutrophil (%) | 82.333 ± 9.225 | 93.667 ± 28.205 | 64.929 ± 36.199 | 0.0702, 0.1404 |
0.0133**, 0.0266* |
| RBC (million/dL) | 6.217 ± 2.310 | 6.784 ± 2.25 | 7.614 ± 3.045 | 0.1600, 0.3200 |
0.1964, 0.3928 |
| Hemoglobin (g/dL) | 13.287 ± 1.961 | 13.847 ± 3.811 | 13.039 ± 2.226 | 0.2861, 0.5723 |
0.1460, 0.2921 |
| Platelets (K/µL) | 269.067 ± 131.412 | 201.667 ± 97.081 | 212.714 ± 96.302 | 0.0281*, 0.0562* |
0.4310, 0.8620 |
| S. Ferritin (ng/mL) | 1187.721 ± 1887.504 | 525.533 ± 286.826 | 123.643 ± 67.068 | 0.0745, 0.1491 |
0.0000**, 0.0000** |
| CRP (mg/L) | 36.100 ± 46.05 | 38.733 ± 15.668 | 29.714 ± 11.391 | 0.4164, 0.8328 |
0.0103**, 0.0206* |
| D-dimer (µg/mL) | 6.387 ± 19.192 | 5.360 ± 14.330 | 1.221 ± 0.611 | 0.2962, 0.5924 |
0.1292, 0.2583 |
| O2 saturation at room air (%) at day 1 | 89.000 ± 2.50 | 89.400 ± 3.961 | 93.929 ± 1.072 | 0.3360, 0.6719 |
0.3948, 0.7897 |
COVID-19, coronavirus disease in 2019; CRP, C-reactive protein; O2, oxygen RBC, red blood cell; RBS, random blood sugar; S. Ferritin, serum ferritin; SOC, standard of care; WBC, white blood count. Data are shown as mean ± standard deviation. Statistical significance was considered when p-value was <0.01 and <0.05 and shown as ** and * mark, respectively. p value = normal value one-tail and bold value two-tail, calculated with 5% level of significance